Thursday, February 23, 2017

Oncogene - Table of Contents alert Volume 36 Issue 8

If you are unable to see the message below, click here to view.


Specific CRISPR/Cas9/Cpf1 antibodies for clean and reliable results

  • Validated for chromatin immunoprecipiation, IP, IF, Western blots 
  • Available from S. pyogenes and S. aureus raised against the N- or C-terminus
  • Polyclonal and monoclonal

Learn more about our large collection of verified Cas9 and Cpf1 antibodies 


Volume 36, Issue 8 (February 2017)

In this issue
Original Articles

Also new
npj Precision Oncology is a new open access, online-only, peer-reviewed journal committed to publishing cutting-edge scientific research in all aspects of precision oncology from basic science to translational applications, to clinical medicine. The journal is part of the Nature Partner Journals series and published in partnership with The Hormel Institute, University of Minnesota.
Explore the benefits of submitting your manuscript.
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Oncogenesis is an online-only, open access journal exploring the molecular basis of cancer and related phenomena. The journal seeks to promote diverse and integrated areas of molecular biology, cell biology, oncology, and genetics.

Explore the benefits of submitting your next research article.

Original Articles


miR-100 antagonism triggers apoptosis by inhibiting ubiquitination-mediated p53 degradation

G Yang, Y Gong, Q Wang, L Wang and X Zhang

Oncogene 2017 36: 1023-1037; advance online publication, August 15, 2016; 10.1038/onc.2016.270

Abstract | Full Text

DEPTOR is a direct NOTCH1 target that promotes cell proliferation and survival in T-cell leukemia

Y Hu, H Su, C Liu, Z Wang, L Huang, Q Wang, S Liu, S Chen, J Zhou, P Li, Z Chen, H Liu and G Qing

Oncogene 2017 36: 1038-1047; advance online publication, September 5, 2016; 10.1038/onc.2016.275

Abstract | Full Text

Cellular stress induces TRB3/USP9x-dependent Notch activation in cancer

J Izrailit, A Jaiswal, W Zheng, M F Moran and M Reedijk

Oncogene 2017 36: 1048-1057; advance online publication, September 5, 2016; 10.1038/onc.2016.276

Abstract | Full Text

Overexpression of PDGFRA cooperates with loss of NF1 and p53 to accelerate the molecular pathogenesis of malignant peripheral nerve sheath tumors OPEN

D H Ki, S He, S Rodig and A T Look

Oncogene 2017 36: 1058-1068; advance online publication, August 1, 2016; 10.1038/onc.2016.269

Abstract | Full Text

Stat3 contributes to cancer progression by regulating Jab1/Csn5 expression

Y Pan, S Wang, B Su, F Zhou, R Zhang, T Xu, R Zhang, V Leventaki, E Drakos, W Liu and F X Claret

Oncogene 2017 36: 1069-1079; advance online publication, August 15, 2016; 10.1038/onc.2016.271

Abstract | Full Text

Rho-associated kinase 1 inhibition is synthetically lethal with von Hippel-Lindau deficiency in clear cell renal cell carcinoma

J M Thompson, Q H Nguyen, M Singh, M W Pavesic, I Nesterenko, L J Nelson, A C Liao and O V Razorenova

Oncogene 2017 36: 1080-1089; advance online publication, November 14, 2016; 10.1038/onc.2016.272

Abstract | Full Text

Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells

Y Deng, J Cheng, B Fu, W Liu, G Chen, Q Zhang and Y Yang

Oncogene 2017 36: 1090-1101; advance online publication, September 5, 2016; 10.1038/onc.2016.273

Abstract | Full Text

RCP induces Slug expression and cancer cell invasion by stabilizing β1 integrin

M H Hwang, K H Cho, K J Jeong, Y-Y Park, J M Kim, S-L Yu, C G Park, G B Mills and H Y Lee

Oncogene 2017 36: 1102-1111; advance online publication, August 15, 2016; 10.1038/onc.2016.277

Abstract | Full Text

The long non-coding RNA, SNHG6-003, functions as a competing endogenous RNA to promote the progression of hepatocellular carcinoma

C Cao, T Zhang, D Zhang, L Xie, X Zou, L Lei, D Wu and L Liu

Oncogene 2017 36: 1112-1122; advance online publication, August 15, 2016; 10.1038/onc.2016.278

Abstract | Full Text

Cancer-associated SF3B1 mutants recognize otherwise inaccessible cryptic 3′ splice sites within RNA secondary structures

A K Kesarwani, O Ramirez, A K Gupta, X Yang, T Murthy, A C Minella and M M Pillai

Oncogene 2017 36: 1123-1133; advance online publication, August 15, 2016; 10.1038/onc.2016.279

Abstract | Full Text

CSN6 controls the proliferation and metastasis of glioblastoma by CHIP-mediated degradation of EGFR

J Hou, Q Deng, J Zhou, J Zou, Y Zhang, P Tan, W Zhang and H Cui

Oncogene 2017 36: 1134-1144; advance online publication, August 22, 2016; 10.1038/onc.2016.280

Abstract | Full Text

UBE2S, a novel substrate of Akt1, associates with Ku70 and regulates DNA repair and glioblastoma multiforme resistance to chemotherapy

L Hu, X Li, Q liu, J Xu, H Ge, Z Wang, H Wang, Z Wang, C Shi, X Xu, J Huang, Z Lin, R O Pieper and C Weng

Oncogene 2017 36: 1145-1156; advance online publication, September 5, 2016; 10.1038/onc.2016.281

Abstract | Full Text

Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression

Y Xu, L Qin, T Sun, H Wu, T He, Z Yang, Q Mo, L Liao and J Xu

Oncogene 2017 36: 1157-1166; advance online publication, August 15, 2016; 10.1038/onc.2016.286

Abstract | Full Text



Claudin-1 induces epithelial-mesenchymal transition through activation of the c-Abl-ERK signaling pathway in human liver cells

Y Suh, C-H Yoon, R-K Kim, E-J Lim, Y S Oh, S-G Hwang, S An, G Yoon, M C Gye, J-M Yi, M-J Kim and S-J Lee

Oncogene 2017 36: 1167-1168; advance online publication, November 14, 2016; 10.1038/onc.2016.294

Full Text

An online-only, open access, multidisciplinary journal dedicated to publishing high-quality original research articles, reviews, editorials, commentaries, and hypothesis generating observations on all areas of breast cancer research. Part of the Nature Partner Journals series, published in partnership with the Breast Cancer Research Foundation.

Now open for submissions >>
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on For event advertising opportunities across the Nature Publishing Group portfolio please contact
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your account at: (You will need to log in to be recognised as a registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group

No comments: